Update on systemic vasculitides. Issue 6 (4th April 2017)

• Record Type: Journal Article
• Authors: Anwar, Siddiq; Karim, M Yousuf
• Is Part Of: Journal of clinical pathology. Volume 70:Issue 6(2017)
• Page Start: 476
• Page End: 482
• Publication Date: 2017-04-04
• Subjects: VASCULITIS -- ANTIBODIES -- AUTOANTIBODY -- IMMUNOLOGY -- LYMPHOCYTES; Pathology -- Periodicals; Pathology, Molecular -- Periodicals; 616.0705
• DOI: 10.1136/jclinpath-2016-203875
• Languages: English
• ISSNs: 0021-9746

Abstract

Abstract : Management of systemic vasculitis has been revolutionised over the last decade with the introduction of targeted biological agents. With an increase in both the prevalence and the recognition of vasculitis as well as the high cost of these agents, it is important to ensure their most optimal utilisation. The goals of vasculitis therapy include the induction and maintenance of remissions, preventing relapses, reducing the toxicity of therapy with the aim of reducing morbidity and mortality as well as improving the quality of life of those afflicted. This review focuses on the recent advances in the diagnosis, surveillance and treatment of these conditions.